跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ESLIPIMAD 400 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ESLIPIMAD 400 MG COMPRIMIDOS EFG
Approved
STANDARD
ESLIPIMAD 400 MG COMPRIMIDOS EFG
Adamed Laboratorios S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 22, 2021
Approval ID
3b5d86f44881188d
Company
Adamed Laboratorios S.L.U.
Type
Standard
Approval Details
Approval Id
3b5d86f44881188d
Drug Cima Aemps Name
ESLIPIMAD 400 MG COMPRIMIDOS EFG
Register Number
86410
Holder Company Name
Adamed Laboratorios S.L.U.
Marketing Company Name
Adamed Laboratorios S.L.U.
Authorization Date
2021-11-22
Dosage Form
COMPRIMIDO
Dose
400 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Adamed Laboratorios S.L.U.
Active Ingredients
ESLICARBAZEPINA ACETATO
400 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 22, 2021
Approval ID
3b5d86f44881188d
Type
Standard
Back to CIMA-AEMPS Approvals